Volume 20, Number 11—November 2014
Mycobacterium ulcerans Infection Imported from Australia to Missouri, USA, 2012
|Patient no., age, y||Location of ulcer||Risk factor||Travel history||Time, wk, to first drug therapy||Final treatment regimen||Time, mo, to diagnosis||Length, mo, of drug therapy||Surgical management||Outcome|
|1, 20||Left foot||None||Nigeria||20||Lamprene, clofazimine||–||–||Amputation below knee||Amputation|
|2, 34||Right elbow||None||Nigeria||–||Surgery alone||7||–||Debridement and split-thickness skin grafting||Cure|
|3, 36||Left calf||Fresh Water||Northern, western, and Central Africa||17||Clarithromycinand ciprofloxacin||8||18||Debridement and split-thickness skin grafting||Cure|
|4, 63||Right calf and left foot||Hiking in Daintree Rainforest in sandals||QLD, Australia||36||Rifampin, clarithromycin, moxifloxacin||9||15||Debridement and split-thickness skin grafting||Cure|
*All patients were male. Except for negative smear results for patient 1, culture and smear results for all patients were positive. QLD, Queensland; –, Information not available.
Page created: October 15, 2014
Page updated: October 15, 2014
Page reviewed: October 15, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.